Columbia, Wyeth-Ayerst Laboratories Inc. regulatory update

COB received a $1.5 million milestone payment from partner Wyeth-Ayerst following approval of Crinone (sustained release, vaginally delivered progesterone) in France for use in in vitro fertilization...